The Best Drug Shortage Management Tools (Germany and EU)

Official shortage lists tell you that a medicine is unavailable. They rarely help you act on it. For purchasing, disposition, hospital pharmacy and reimporters, the useful question is not where the list is, but which tool turns a shortage into a decision: a current status, a concrete alternative, an import route, and a signal when the product is back. This guide compares the tool types, official lists, monitoring software and integrated platforms, for German and EU professional buyers. It is written for professionals, not patients.

What counts as a drug shortage in Germany and the EU?

In Germany the BfArM (Federal Institute for Drugs and Medical Devices) defines a supply shortage as a delivery interruption of more than two weeks, or a demand that noticeably exceeds supply. At EU level the European Medicines Agency (EMA) coordinates a shortages catalogue and a Union list of critical medicines. The German ALBVVG law, in force since 2023, added reporting and supply obligations for manufacturers and wholesalers.

These definitions matter because a tool is only useful if it reflects them in real time. A weekly PDF and a live purchasing feed are not the same instrument, even if they carry the same underlying notifications.

What official shortage lists exist, and where do they stop?

The official layer is authoritative but deliberately narrow. The BfArM shortage list and PharmNet.Bund publish reported shortages for Germany. The EMA catalogue and the Union list of critical medicines cover the EU level. All of them answer one question: is this product reported as short? They do not suggest a specific alternative, they do not route an EU import, and they do not alert you when the product returns. That gap is where purchasing time is actually spent.

Official list vs monitoring tool vs integrated platform

Three categories address shortages, and they are not interchangeable:

• Official lists. Authoritative status data from BfArM and EMA, free, but status only.
• Monitoring software. Several commercial tools forecast shortages, but the established products are built on United States FDA and ASHP data and do not cover the German or EU market, which makes them a poor fit for a DACH or EU buyer.
• Integrated platforms. They tie shortage data to the article master, suggest alternatives including EU import, and can alert the buyer, so the shortage becomes an action rather than a lookup.

Drug shortage tools compared

The table scores the categories on the capabilities that decide whether a shortage can be resolved, not just observed.

How do I find a therapeutic or EU-import alternative fast?

Finding a usable alternative follows a clear order:

1. Look for a directly substitutable product with the same active ingredient, strength and form.
2. Check another strength or package size that can be adjusted on the prescription.
3. Identify an EU import or single-import option for an equivalent product marketed abroad.
4. As a last resort, consider a compounded preparation.

An integrated platform runs these steps against consolidated data, so the alternative and its availability appear in the same result. The underlying German data is described in our drug shortage database for Germany.

How do I get alerted when a discontinued PZN is available again?

The most time-consuming part of shortage management is re-checking. pharmazie.com sends a proactive email alert when a long-term-unavailable PZN becomes available again at one of the buyer's own suppliers, so nobody has to poll wholesaler portals by hand. This reactivation alert is the single capability that official lists and most monitoring tools do not offer.

What should wholesale purchasing, hospital pharmacy and reimporters look for?

The priorities differ by role. Wholesale purchasing needs the alert plus purchasing integration through an API or MSV3. Hospital pharmacy needs clinically sound alternatives and interaction safety alongside availability. Reimporters need the EU import angle and cross-border product data. For choosing the underlying data source, see our comparison of German drug databases.

Conclusion

Official lists remain the authoritative source of truth, but they stop at status. The useful tool is the one that adds the three things they lack: daily-updated data tied to BfArM notifications, concrete alternatives including EU import, and a proactive alert when a product returns. pharmazie.com is the consolidated pharmaceutical data platform by DACON Datenbank Consulting GmbH that bundles 25+ specialist databases into a single search, exclusively for healthcare professionals, with product data across 50+ countries updated daily. The clearest way to see the shortage workflow is a short demo.

Further reading: Drug shortage database Germany · German drug databases compared

See the shortage workflow: book a demo